SCHEMBL8300115

SCHEMBL8300115

CC(=O)C(=O)NC(C)c1ccc(Cl)cc1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.55
HPGD P15428 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
ALDH1A1 P00352 2/20 0.49
PRCP P42785 1/20 0.48
BRD4 O60885 1/20 0.47
FFAR2 O15552 1/20 0.46
GPR139 Q6DWJ6 1/20 0.46
BCL2 P10415 1/20 0.43
BCL2L1 Q07817 1/20 0.43
MCL1 Q07820 1/20 0.43
BCL2A1 Q16548 1/20 0.43
BAK1 Q16611 1/20 0.43
GRIN2B Q13224 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2651517 0.85 GAA (0.58) GAAHPGDSMN1; SMN2ALDH1A1PRCP
SCHEMBL7674958 0.85 GAA (0.58) GAAHPGDSMN1; SMN2ALDH1A1PRCP
SCHEMBL2651519 0.85 GAA (0.58) GAAHPGDSMN1; SMN2ALDH1A1PRCP
SCHEMBL10315770 0.83 L3MBTL1 (0.45) HPGDALDH1A1GPR139
SCHEMBL8300135 0.81 HTT (0.58) ALDH1A1MEN1KMT2A
SCHEMBL8300122 0.81 HSD17B10 (0.58) HPGDALDH1A1MEN1KMT2A
SCHEMBL12707460 0.81 HSD17B10 (0.58) HPGDALDH1A1MEN1KMT2A
SCHEMBL22279548 0.81 GAA (0.58) GAAHPGDSMN1; SMN2ALDH1A1PRCP
SCHEMBL12291882 0.81 HSD17B10 (0.58) HPGDALDH1A1MEN1KMT2A
SCHEMBL6392377 0.81 GAA (0.58) GAAHPGDSMN1; SMN2ALDH1A1PRCP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2573083-A1 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-03-27 EP disclosed
WO-2005035525-A2 2-AMIDO-4-ARYLOXY-1-CARBONYLPYRROLIDINE DERIVATIVES AS INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2005-04-21 WO disclosed